Performance of BIIB Biogen | -31% in 12m
Compare BIIB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Biogen with its related Sector/Index XBI
Performance Duell BIIB vs XBI
| TimeFrame | BIIB | XBI |
|---|---|---|
| 1 Day | -1.21% | 1.16% |
| 1 Week | 5.46% | 7.44% |
| 1 Month | 2.83% | -2.58% |
| 3 Months | -12.4% | 0.42% |
| 6 Months | -11.7% | 29.44% |
| 12 Months | -31.0% | 10.82% |
| YTD | -20.3% | -2.09% |
| Rel. Perf. 1m | 0.75 | |
| Rel. Perf. 3m | -1.89 | |
| Rel. Perf. 6m | -3.90 | |
| Rel. Perf. 12m | -4.31 |
Is Biogen a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Biogen is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.19 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BIIB as of May 2024 is 184.54. This means that BIIB is currently overvalued and has a potential downside of -13.57% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BIIB as of May 2024 is 184.54. This means that BIIB is currently overvalued and has a potential downside of -13.57% (Sold with Premium).
Is BIIB a buy, sell or hold?
- Strong Buy: 16
- Buy: 9
- Hold: 9
- Sell: 0
- Strong Sell: 0
Values above 0%: BIIB is performing better - Values below 0%: BIIB is underperforming
Compare BIIB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.15% | 5.49% | -29.80% | -55.68% |
| US NASDAQ 100 | QQQ | 4.88% | 6.05% | -29.63% | -65.53% |
| US Dow Jones Industrial 30 | DIA | 5.12% | 5.18% | -25.73% | -46.63% |
| German DAX 40 | DBXD | 5.65% | 5.11% | -29.57% | -44.11% |
| UK FTSE 100 | ISFU | 4.18% | 0.11% | -26.27% | -40.52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.53% | -0.52% | -16.35% | -21.02% |
| Hongkong Hang Seng | HSI | -1.41% | -3.37% | -12.22% | -16.50% |
| Japan Nikkei 225 | EXX7 | 3.10% | 8.19% | -25.59% | -50.77% |
| India NIFTY 50 | INDA | 4.14% | 0.10% | -32.60% | -60.25% |
| Brasil Bovespa | EWZ | 2.31% | 3.55% | -16.05% | -54.35% |
BIIB Biogen vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.65% | 6.23% | -31.62% | -67.26% |
| Consumer Discretionary | XLY | 4.09% | 4.56% | -24.01% | -52.49% |
| Consumer Staples | XLP | 5.59% | 2.45% | -23.54% | -31.71% |
| Energy | XLE | 9.67% | 6.85% | -19.31% | -49.91% |
| Financial | XLF | 6.49% | 5.73% | -34.13% | -58.35% |
| Health Care | XLV | 5.06% | 5.40% | -23.42% | -37.81% |
| Industrial | XLI | 5.90% | 4.83% | -33.82% | -55.57% |
| Materials | XLB | 5.84% | 6.84% | -27.19% | -44.42% |
| Real Estate | XLRE | 4.64% | 7.20% | -20.68% | -34.45% |
| Technology | XLK | 5.73% | 7.56% | -28.08% | -63.85% |
| Utilities | XLU | 4.04% | -1.01% | -24.04% | -33.82% |
| Aerospace & Defense | XAR | 2.63% | 1.81% | -27.47% | -52.05% |
| Biotech | XBI | -1.98% | 5.41% | -41.16% | -41.79% |
| Homebuilder | XHB | 4.43% | 6.84% | -49.48% | -79.47% |
| Retail | XRT | 5.07% | 7.76% | -32.67% | -51.98% |
Does Biogen outperform its market, is BIIB a Sector Leader?
No, over the last 12 months Biogen (BIIB) made -30.97%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months BIIB made -12.40%, while XBI made 0.42%.
No, over the last 12 months Biogen (BIIB) made -30.97%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months BIIB made -12.40%, while XBI made 0.42%.
| Period | BIIB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.83% | -2.58% | -2.66% |
| 3 Months | -12.40% | 0.42% | 2.48% |
| 12 Months | -30.97% | 10.82% | 24.71% |